<?xml version="1.0"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/"><rdf:Description rdf:about="https://dk.um.si/IzpisGradiva.php?id=92747"><dc:title>Optimisation of the green process of industrial hemp - preparation and its extract characterisation</dc:title><dc:creator>Žitek Makoter,	Taja	(Avtor)
	</dc:creator><dc:creator>Kotnik,	Petra	(Avtor)
	</dc:creator><dc:creator>Makoter,	Teo	(Avtor)
	</dc:creator><dc:creator>Postružnik,	Vesna	(Avtor)
	</dc:creator><dc:creator>Knez,	Željko	(Avtor)
	</dc:creator><dc:creator>Knez Marevci,	Maša	(Avtor)
	</dc:creator><dc:subject>supercritical fluid extraction</dc:subject><dc:subject>ultrasonic extraction</dc:subject><dc:subject>melanoma cells</dc:subject><dc:subject>extraction</dc:subject><dc:subject>WM-266-4</dc:subject><dc:description>Natural medicines and products are becoming increasingly important in the pharmaceutical
and food industries. The most important step in obtaining a natural remedy is the processing of
the natural material. This study offers the separation of the industrial hemp plant into fractions by
mechanical treatment, which has a significant impact on the selectivity of the obtained fractions. This
study also offers a solution to reduce waste by fractionating industrial hemp, focusing on the fraction
with the highest cannabinoid content (49.5% of CBD). The study confirmed the anticancer potential
of the extract, which prevents further division of WM-266-4 melanoma cells at a concentration of
10−3 mg/mL. However, application of the extract (c = 10−3 mg/mL) to normal human epidermal
melanocytes proved to be insignificant, as the metabolic activity of the cells was the same as in the
control cell group.</dc:description><dc:publisher>MDPI</dc:publisher><dc:date>2022</dc:date><dc:date>2025-05-09 14:06:16</dc:date><dc:type>Članek v reviji</dc:type><dc:identifier>92747</dc:identifier><dc:language>sl</dc:language><dc:rights>© 2022 by the authors</dc:rights></rdf:Description></rdf:RDF>
